Safety Assessment of a Potential Anti-diabetic Agent in a Pre-clinical Model
Saved in:
| Main Authors: | Md Abu Bakkar Siddik, Vijay Hedge, Masoud Nateqi, Nikhil Dhurandhar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Current Developments in Nutrition |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475299125015355 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antidiabetic E4orf1 protein prevents hepatic steatosis and reduces markers of aging-related cellular damage in high fat fed older mice
by: Zahra Mostofinejad, et al.
Published: (2021-03-01) -
A 70 Amino Acid Fragment of Insparin Retains Its Potential to Upregulate Distal Insulin Signaling
by: Tanvi Kale, et al.
Published: (2025-05-01) -
From commitment to action: unraveling the pathways from top management commitment to environmental sustainability in the Chinese banking sector
by: Huawei Tian, et al.
Published: (2024-12-01) -
Acute and Long-Term Effects of Insparin and Pioglitazone on Tissue Distribution of Glucose Uptake
by: Sara Ranjbar, et al.
Published: (2025-05-01) -
E4orf1 Enhances Glycemic Regulation, Cognitive Function, and Obesity-Linked Molecular Pathways in a Male Mouse Model of Obesity-Associated Alzheimer’s Disease
by: Vijay Hegde, et al.
Published: (2025-05-01)